ATE470435T1 - Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set - Google Patents

Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Info

Publication number
ATE470435T1
ATE470435T1 AT04799314T AT04799314T ATE470435T1 AT E470435 T1 ATE470435 T1 AT E470435T1 AT 04799314 T AT04799314 T AT 04799314T AT 04799314 T AT04799314 T AT 04799314T AT E470435 T1 ATE470435 T1 AT E470435T1
Authority
AT
Austria
Prior art keywords
mucosa
treatment
charged lipid
disorder
medicament
Prior art date
Application number
AT04799314T
Other languages
English (en)
Inventor
Yechezkel Barenholz
Abraham Rubinstein
Tareq Jubeh
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE470435T1 publication Critical patent/ATE470435T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT04799314T 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set ATE470435T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51631603P 2003-11-03 2003-11-03
PCT/IL2004/001005 WO2005041932A2 (en) 2003-11-03 2004-11-03 Method for selecting cationic or anionic liposomes for treatment of a mucosa membrane, and kit comprising the same

Publications (1)

Publication Number Publication Date
ATE470435T1 true ATE470435T1 (de) 2010-06-15

Family

ID=34549524

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04799314T ATE470435T1 (de) 2003-11-03 2004-11-03 Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set

Country Status (5)

Country Link
US (1) US20070212403A1 (de)
EP (1) EP1694298B1 (de)
AT (1) ATE470435T1 (de)
DE (1) DE602004027655D1 (de)
WO (1) WO2005041932A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060015534A (ko) 2003-04-25 2006-02-17 더 펜 스테이트 리서치 파운데이션 성장 억제, 지질 유래된 생활성 화합물의 전신 전달을 위한방법 및 시스템
US20070087045A1 (en) * 2005-10-14 2007-04-19 Industrial Technology Research Institute Lipid carrier and method of preparing the same
WO2008087803A1 (ja) * 2007-01-16 2008-07-24 Hokkaido University 抗酸化成分を封入したイオントフォレーシス用リポソーム製剤
EP2368627A4 (de) * 2008-12-24 2015-01-14 Biomedcore Inc Verfahren zur herstellung von liposomen und verfahren zur cholesterinauflösung
AU2012217685B2 (en) 2011-02-15 2017-05-18 Merrimack Pharmaceuticals, Inc. Compositions and methods for delivering nucleic acid to a cell
CN102192978B (zh) * 2011-03-15 2013-09-04 中国科学院武汉病毒研究所 评价作用于体内粘膜的药物和外源物安全性的方法及应用
US20220296514A1 (en) * 2021-03-18 2022-09-22 FormuRx Pharmaceuticals Co., Ltd. Composition and Method of Preparation for Lipid Formulations Comprising Charged Lipids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0714865B2 (ja) * 1986-10-28 1995-02-22 武田薬品工業株式会社 リポソ−ム製剤およびその製造法
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
AU3614493A (en) * 1992-02-04 1993-09-01 Chiron Corporation Non-toxic lipid vaccine formulations
US20020039556A1 (en) * 1995-09-27 2002-04-04 Kari Dyvik Stabilised phospholipid compositions
AU753196B2 (en) * 1998-02-09 2002-10-10 Bracco Research S.A. Targeted delivery of biologically active media
US6872406B2 (en) * 2000-02-11 2005-03-29 Children's Hospital Research Foundation Fusogenic properties of saposin C and related proteins and polypeptides for application to transmembrane drug delivery systems
US6616944B2 (en) * 2000-03-08 2003-09-09 Medinnova Gesellschaft Fur Medizinsche Innovationen Aus Adkademischer Forschung Mbh Self-assembling colloidal carriers for protein delivery
GB0111279D0 (en) * 2001-05-10 2001-06-27 Nycomed Imaging As Radiolabelled liposomes
WO2003002142A1 (fr) * 2001-06-29 2003-01-09 Chugai Seiyaku Kabushiki Kaisha Vaccin anticarcinogene contenant un antigene tumoral base sur un produit de gene wt1 suppresseur de tumeur et des liposomes cationiques

Also Published As

Publication number Publication date
EP1694298A2 (de) 2006-08-30
EP1694298B1 (de) 2010-06-09
WO2005041932A3 (en) 2005-06-02
US20070212403A1 (en) 2007-09-13
WO2005041932A2 (en) 2005-05-12
DE602004027655D1 (de) 2010-07-22

Similar Documents

Publication Publication Date Title
Salar et al. Potential inhibition of demineralization in vitro by fluoride-releasing sealants
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE309802T1 (de) Verwendung von cyclopamine zur behandlung von psoriasis und anderen hauterkrankungen
MY173699A (en) Novel compounds for the treatment of diseases associated with amyloid of amyloid-like proteins
CY1107780T1 (el) Μεθοδος για τη θεραπεια οφθαλμικων νεοαγγειακων ασθενειων
Motta et al. Aesthetic restoration of deciduous anterior teeth after removal of carious tissue with papacarie®
BR112013005673A2 (pt) uso de lipase de ácido lisossomal para tratamento de deficiência de lipase de ácido lisossomal em pacientes
DE60320095D1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
Yang et al. Sihler-stain study of buccal nerve distribution and its clinical implications
IL174525A0 (en) Medicamentously targeted local lipolysis
MXPA05012392A (es) Tratamientos de ansiedad con ziprasidona.
ATE260282T1 (de) Aromatische ester von camptothecinen und verfahren zur behandlung von krebserkrankungen
DE602004027655D1 (de) Verfahren zur auswahl von kationischen oder anionischen liposomen zur behandlung einer schleimhautmembran und diese enthaltendes set
WO2023043870A8 (en) Chewing gum formulation of lsd and methods of use thereof
DE60140960D1 (de) Verwendung von serp-1 in kombination mit einem immunosuppressor zur behandlung von arthritis
BRPI0407693A (pt) uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos
MX2023002350A (es) Composiciones y metodos para mejorar enfermedades y trastornos neurologicos.
ATE398456T1 (de) Verwendung von negativ-geladenen phospholipiden zur herstellung eines medikaments zur behandlung und/oder vorbeugung von makuladegeneration
ATE338558T1 (de) Verwendung von phosphoglyzeriden enthaltend phosphoglycero-ether zur behandlung neurodegenerativer erkrankungen in geistig schwer behinderten kindern
ATE290384T1 (de) Etherlysophospholipide zur behandlung von chronischen entzündlichen erkrankungen
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
ATE376425T1 (de) Verfahren zur behandlung bestimmter augenkrankheiten
RU2446839C1 (ru) Способ комплексного лечения больных с воспалительными заболеваниями придаточных пазух носа
WO2008070284A3 (en) Amyloid beta peptides and methods of uses thereof
WO2021034996A3 (en) Treatment of cardiovascular diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties